Spruce Biosciences Inc.

NASDAQ: SPRB · Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Spruce Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
4.91M 10.09M n/a n/a
Cost of Revenue
n/a n/a 429K 381K
Gross Profit
4.91M 10.09M -429K -381K
Operating Income
-56.15M -51.99M -47.28M -42.07M
Interest Income
3.42M 4.56M 1.52M 119K
Pretax Income
-53.04M -47.92M -46.18M -42.29M
Net Income
-53.04M -47.92M -46.18M -42.69M
Selling & General & Admin
14.64M 12.65M 12.09M 11.37M
Research & Development
46.42M 49.43M 35.2M 30.7M
Other Expenses
n/a n/a n/a 119K
Operating Expenses
61.06M 62.08M 47.28M 42.07M
Interest Expense
307K 483K 420K 345K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
61.06M 62.08M 47.28M 42.07M
Income Tax Expense
n/a n/a n/a 396K
Shares Outstanding (Basic)
536.44K 500.63K 611.71K 607.4K
Shares Outstanding (Diluted)
536.44K 500.63K 611.71K 607.4K
EPS (Basic)
-96.75 -93 -72 -68.25
EPS (Diluted)
-96.75 -93 -72 -68.25
EBITDA
-52.68M -47.37M -45.33M -41.57M
EBIT
-52.73M -47.44M -45.76M -41.95M
Depreciation & Amortization
46K 70K 429K 381K